302 related articles for article (PubMed ID: 19215279)
1. Visual fields at school-age in children treated with vigabatrin in infancy.
Gaily E; Jonsson H; Lappi M
Epilepsia; 2009 Feb; 50(2):206-16. PubMed ID: 19215279
[TBL] [Abstract][Full Text] [Related]
2. Vigabatrin and epilepsy: lessons learned.
Wild JM; Ahn HS; Baulac M; Bursztyn J; Chiron C; Gandolfo E; Safran AB; Schiefer U; Perucca E
Epilepsia; 2007 Jul; 48(7):1318-27. PubMed ID: 17635558
[TBL] [Abstract][Full Text] [Related]
3. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
Camposano SE; Major P; Halpern E; Thiele EA
Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
[TBL] [Abstract][Full Text] [Related]
4. Vigabatrin retinopathy in an Irish cohort: lack of correlation with dose.
Kinirons P; Cavalleri GL; O'Rourke D; Doherty CP; Reid I; Logan P; Liggan B; Delanty N
Epilepsia; 2006 Feb; 47(2):311-7. PubMed ID: 16499754
[TBL] [Abstract][Full Text] [Related]
5. Vigabatrin therapy in infantile spasms.
Kankirawatana P; Raksadawan N; Balangkura K
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S778-83. PubMed ID: 12403260
[TBL] [Abstract][Full Text] [Related]
6. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
[TBL] [Abstract][Full Text] [Related]
7. Visual fields in young children treated with vigabatrin.
Agrawal S; Mayer DL; Hansen RM; Fulton AB
Optom Vis Sci; 2009 Jun; 86(6):767-73. PubMed ID: 19417698
[TBL] [Abstract][Full Text] [Related]
8. Visual field loss in young children and mentally handicapped adolescents receiving vigabatrin.
Werth R; Schädler G
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3028-35. PubMed ID: 16799049
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of West syndrome].
Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
[TBL] [Abstract][Full Text] [Related]
10. Visual field constriction is not limited to children treated with vigabatrin.
Wohlrab G; Boltshauser E; Schmitt B; Schriever S; Landau K
Neuropediatrics; 1999 Jun; 30(3):130-2. PubMed ID: 10480207
[TBL] [Abstract][Full Text] [Related]
11. Is visual field constriction in epilepsy patients treated with vigabatrin reversible?
Schmidt T; Rüther K; Jokiel B; Pfeiffer S; Tiel-Wilck K; Schmitz B
J Neurol; 2002 Aug; 249(8):1066-71. PubMed ID: 12195456
[TBL] [Abstract][Full Text] [Related]
12. [Vigabatrin and alterations of the visual field].
Argumosa A; Herranz JL; Arteaga R; Barrasa J; Calles L; Armijo J
Rev Neurol; 1999 Apr 16-30; 28(8):741-5. PubMed ID: 10363313
[TBL] [Abstract][Full Text] [Related]
13. Retinal nerve fibre layer attenuation: clinical indicator for vigabatrin toxicity.
Moseng L; Sæter M; Mørch-Johnsen GH; Hoff JM; Gajda A; Brodtkorb E; Midelfart A
Acta Ophthalmol; 2011 Aug; 89(5):452-8. PubMed ID: 21251242
[TBL] [Abstract][Full Text] [Related]
14. Vigabatrin-associated visual field defects in children.
Russell-Eggitt IM; Mackey DA; Taylor DS; Timms C; Walker JW
Eye (Lond); 2000 Jun; 14 ( Pt 3A)():334-9. PubMed ID: 11026995
[TBL] [Abstract][Full Text] [Related]
15. Binasal visual field defects are not specific to vigabatrin.
Gonzalez P; Sills GJ; Parks S; Kelly K; Stephen LJ; Keating D; Dutton GN; Brodie MJ
Epilepsy Behav; 2009 Nov; 16(3):521-6. PubMed ID: 19815465
[TBL] [Abstract][Full Text] [Related]
16. Vigabatrin-attributable visual field defects in patients with intractable partial epilepsy.
Tseng YL; Lan MY; Lai SL; Huang FC; Tsai JJ
Acta Neurol Taiwan; 2006 Dec; 15(4):244-50. PubMed ID: 17214087
[TBL] [Abstract][Full Text] [Related]
17. In utero exposure to vigabatrin: no indication of visual field loss.
Lawthom C; Smith PE; Wild JM
Epilepsia; 2009 Feb; 50(2):318-21. PubMed ID: 18616557
[TBL] [Abstract][Full Text] [Related]
18. Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study.
Riikonen R; Rener-Primec Z; Carmant L; Dorofeeva M; Hollody K; Szabo I; Krajnc BS; Wohlrab G; Sorri I
Dev Med Child Neurol; 2015 Jan; 57(1):60-7. PubMed ID: 25145415
[TBL] [Abstract][Full Text] [Related]
19. Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre study.
Wild JM; Chiron C; Ahn H; Baulac M; Bursztyn J; Gandolfo E; Goldberg I; Goñi FJ; Mercier F; Nordmann JP; Safran AB; Schiefer U; Perucca E
CNS Drugs; 2009 Nov; 23(11):965-82. PubMed ID: 19845417
[TBL] [Abstract][Full Text] [Related]
20. Visual field constriction in 91 Finnish children treated with vigabatrin.
Vanhatalo S; Nousiainen I; Eriksson K; Rantala H; Vainionpää L; Mustonen K; Aärimaa T; Alen R; Aine MR; Byring R; Hirvasniemi A; Nuutila A; Walden T; Ritanen-Mohammed UM; Karttunen-Lewandowski P; Pohjola LM; Kaksonen S; Jurvelin P; Granström ML
Epilepsia; 2002 Jul; 43(7):748-56. PubMed ID: 12102679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
